Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Interleukin-7 expression in tears and orbital tissues of patients with Graves' ophthalmopathy.

Cai K, Wei R.

Endocrine. 2013 Aug;44(1):140-4. doi: 10.1007/s12020-012-9840-7. Epub 2012 Nov 28.

PMID:
23188693
2.

Graves' orbitopathy results in profound changes in tear composition: a study of plasminogen activator inhibitor-1 and seven cytokines.

Ujhelyi B, Gogolak P, Erdei A, Nagy V, Balazs E, Rajnavolgyi E, Berta A, Nagy EV.

Thyroid. 2012 Apr;22(4):407-14. doi: 10.1089/thy.2011.0248. Epub 2012 Mar 2.

PMID:
22385289
3.

Role of macrophage infiltration in the orbital fat of patients with Graves' ophthalmopathy.

Chen MH, Chen MH, Liao SL, Chang TC, Chuang LM.

Clin Endocrinol (Oxf). 2008 Aug;69(2):332-7. doi: 10.1111/j.1365-2265.2008.03219.x. Epub 2008 Feb 12.

PMID:
18284633
4.

TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients.

Wakelkamp IM, Bakker O, Baldeschi L, Wiersinga WM, Prummel MF.

Clin Endocrinol (Oxf). 2003 Mar;58(3):280-7.

PMID:
12608932
5.

Changes of lacrimal gland and tear inflammatory cytokines in thyroid-associated ophthalmopathy.

Huang D, Luo Q, Yang H, Mao Y.

Invest Ophthalmol Vis Sci. 2014 Jul 3;55(8):4935-43. doi: 10.1167/iovs.13-13704.

PMID:
24994866
6.

Increased response to oxidative stress challenge in Graves' ophthalmopathy orbital fibroblasts.

Tsai CC, Wu SB, Cheng CY, Kao SC, Kau HC, Lee SM, Wei YH.

Mol Vis. 2011;17:2782-8. Epub 2011 Oct 26.

7.
8.

Increased oxidative DNA damage, lipid peroxidation, and reactive oxygen species in cultured orbital fibroblasts from patients with Graves' ophthalmopathy: evidence that oxidative stress has a role in this disorder.

Tsai CC, Wu SB, Cheng CY, Kao SC, Kau HC, Chiou SH, Hsu WM, Wei YH.

Eye (Lond). 2010 Sep;24(9):1520-5. doi: 10.1038/eye.2010.31. Epub 2010 Mar 19.

PMID:
20300129
9.

Anti-inflammatory effect of quercetin in a whole orbital tissue culture of Graves' orbitopathy.

Yoon JS, Chae MK, Lee SY, Lee EJ.

Br J Ophthalmol. 2012 Aug;96(8):1117-21. doi: 10.1136/bjophthalmol-2012-301537. Epub 2012 Jun 2.

PMID:
22661653
10.

Oxidative stress and antioxidant activity in orbital fibroadipose tissue in Graves' ophthalmopathy.

Hondur A, Konuk O, Dincel AS, Bilgihan A, Unal M, Hasanreisoglu B.

Curr Eye Res. 2008 May;33(5):421-7. doi: 10.1080/02713680802123532.

PMID:
18568878
11.

The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy.

Prummel MF, Gerding MN, Zonneveld FW, Wiersinga WM.

Clin Endocrinol (Oxf). 2001 Feb;54(2):205-9.

PMID:
11207635
12.

Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy.

Huang D, Xu N, Song Y, Wang P, Yang H.

Graefes Arch Clin Exp Ophthalmol. 2012 Apr;250(4):619-25. doi: 10.1007/s00417-011-1863-x. Epub 2011 Nov 30.

PMID:
22124787
13.

Increased serum interleukin-17 in Graves' ophthalmopathy.

Kim SE, Yoon JS, Kim KH, Lee SY.

Graefes Arch Clin Exp Ophthalmol. 2012 Oct;250(10):1521-6. doi: 10.1007/s00417-012-2092-7. Epub 2012 Jul 1.

PMID:
22752189
14.

Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.

Zhang C, Zhang X, Ma L, Peng F, Huang J, Han H.

Endocrine. 2012 Apr;41(2):248-55. doi: 10.1007/s12020-012-9600-8. Epub 2012 Jan 12.

PMID:
22237514
15.

Analysis of Graves' ophthalmopathy patients' tear protein spectrum.

Jiang LH, Wei RL.

Chin Med J (Engl). 2013 Dec;126(23):4493-8.

PMID:
24286413
16.

Detection and modulation of interleukin-1 receptor antagonist messenger ribonucleic acid and immunoreactivity in Graves' orbital fibroblasts.

Mühlberg T, Heberling HJ, Joba W, Schworm HD, Heufelder AE.

Invest Ophthalmol Vis Sci. 1997 Apr;38(5):1018-28.

PMID:
9112998
17.

Circulating levels of miR-146a and IL-17 are significantly correlated with the clinical activity of Graves' ophthalmopathy.

Wei H, Guan M, Qin Y, Xie C, Fu X, Gao F, Xue Y.

Endocr J. 2014;61(11):1087-92. Epub 2014 Aug 7.

18.

Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves' ophthalmopathy.

Khoo TK, Coenen MJ, Schiefer AR, Kumar S, Bahn RS.

Thyroid. 2008 Dec;18(12):1291-6. doi: 10.1089/thy.2008.0255.

20.

Orbit-infiltrating mast cells, monocytes, and macrophages produce PDGF isoforms that orchestrate orbital fibroblast activation in Graves' ophthalmopathy.

van Steensel L, Paridaens D, van Meurs M, van Hagen PM, van den Bosch WA, Kuijpers RW, Drexhage HA, Hooijkaas H, Dik WA.

J Clin Endocrinol Metab. 2012 Mar;97(3):E400-8. doi: 10.1210/jc.2011-2697. Epub 2012 Jan 11.

PMID:
22238384

Supplemental Content

Support Center